BLUE logo

Bluebird Bio (BLUE) Long Term Liabilities

Annual Total Long Term Liabilities

$224.51 M
-$54.39 M-19.50%

31 December 2023

BLUE Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Liabilities

$174.81 M
-$19.47 M-10.02%

30 September 2024

BLUE Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BLUE Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-19.5%-24.7%
3 y3 years+0.8%-13.7%
5 y5 years+6.2%-22.1%

BLUE Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-19.5%+237.5%-37.3%+162.8%
5 y5 years-19.5%+237.5%-37.3%+162.8%
alltimeall time-19.5%+897.6%-37.3%+910.2%

Bluebird Bio Long Term Liabilities History

DateAnnualQuarterly
Sept 2024
-
$174.81 M(-10.0%)
June 2024
-
$194.28 M(-6.1%)
Mar 2024
-
$206.86 M(-7.9%)
Dec 2023
$224.51 M(-19.5%)
$224.51 M(-3.3%)
Sept 2023
-
$232.12 M(-3.0%)
June 2023
-
$239.36 M(+7.8%)
Mar 2023
-
$222.06 M(-20.4%)
Dec 2022
$278.90 M(+319.2%)
$278.90 M(+18.9%)
Sept 2022
-
$234.51 M(-4.1%)
June 2022
-
$244.62 M(+188.1%)
Mar 2022
-
$84.92 M(+27.7%)
Dec 2021
$66.53 M(-70.1%)
$66.53 M(-67.2%)
Sept 2021
-
$202.56 M(-8.8%)
June 2021
-
$222.13 M(-3.7%)
Mar 2021
-
$230.63 M(+3.6%)
Dec 2020
$222.61 M(+1.7%)
$222.61 M(-1.3%)
Sept 2020
-
$225.56 M(-1.3%)
June 2020
-
$228.58 M(+1.9%)
Mar 2020
-
$224.25 M(+2.5%)
Dec 2019
$218.85 M(+3.6%)
$218.85 M(-2.5%)
Sept 2019
-
$224.48 M(-0.2%)
June 2019
-
$224.86 M(+2.3%)
Mar 2019
-
$219.82 M(+4.0%)
Dec 2018
$211.34 M
$211.34 M(-3.7%)
DateAnnualQuarterly
Sept 2018
-
$219.36 M(+16.9%)
June 2018
-
$187.72 M(-0.6%)
Mar 2018
-
$188.85 M(+4.0%)
Dec 2017
$181.52 M(+4.2%)
$181.52 M(-3.3%)
Sept 2017
-
$187.64 M(+4.7%)
June 2017
-
$179.27 M(-2.9%)
Mar 2017
-
$184.56 M(+6.0%)
Dec 2016
$174.15 M(+56.2%)
$174.15 M(+11.5%)
Sept 2016
-
$156.16 M(+10.0%)
June 2016
-
$142.00 M(+6.6%)
Mar 2016
-
$133.23 M(+19.5%)
Dec 2015
$111.47 M(+395.3%)
$111.47 M(+17.3%)
Sept 2015
-
$95.06 M(+82.2%)
June 2015
-
$52.17 M(+201.5%)
Mar 2015
-
$17.30 M(-23.1%)
Dec 2014
$22.50 M(-40.5%)
$22.50 M(-24.4%)
Sept 2014
-
$29.78 M(-15.7%)
June 2014
-
$35.32 M(+9.4%)
Mar 2014
-
$32.30 M(-14.7%)
Dec 2013
$37.85 M(-68.6%)
$37.85 M(-3.1%)
Sept 2013
-
$39.07 M(-9.0%)
June 2013
-
$42.92 M(-12.9%)
Mar 2013
-
$49.26 M(-59.1%)
Dec 2012
$120.44 M(+43.8%)
$120.44 M
Dec 2011
$83.73 M
-

FAQ

  • What is bluebird bio annual total long term liabilities?
  • What is the all time high annual total long term liabilities for bluebird bio?
  • What is bluebird bio annual total long term liabilities year-on-year change?
  • What is bluebird bio quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for bluebird bio?
  • What is bluebird bio quarterly long term liabilities year-on-year change?

What is bluebird bio annual total long term liabilities?

The current annual total long term liabilities of BLUE is $224.51 M

What is the all time high annual total long term liabilities for bluebird bio?

bluebird bio all-time high annual total long term liabilities is $278.90 M

What is bluebird bio annual total long term liabilities year-on-year change?

Over the past year, BLUE annual total long term liabilities has changed by -$54.39 M (-19.50%)

What is bluebird bio quarterly total long term liabilities?

The current quarterly long term liabilities of BLUE is $174.81 M

What is the all time high quarterly long term liabilities for bluebird bio?

bluebird bio all-time high quarterly total long term liabilities is $278.90 M

What is bluebird bio quarterly long term liabilities year-on-year change?

Over the past year, BLUE quarterly total long term liabilities has changed by -$57.30 M (-24.69%)